Aristotle University Of Thessaloniki (AUTH)
Μελέτη αντοχής στην άσκηση και συσχέτιση με σύγχρονους υπερηχογραφικούς δείκτες σε ασθενείς με καρδιακή ανεπάρκεια και σιδηροπενία
Abstract
dc:descriptionHeart failure with reduced ejection fraction (HFrEF) is frequently accompanied by iron deficiency and is associated with increased morbidity, mortality, and reduced exercise capacity. Intravenous administration of ferric carboxymaltose (FCM) improves functional status and symptoms in these patients, while also reducing the risk of HF hospitalization and cardiovascular mortality. The aim of the present doctoral thesis was to investigate the mechanistic basis of these observed benefits by evaluating the impact of iron deficiency correction through intravenous FCM on left ventricular (LV), left atrial (LA), and right ventricular (RV) morphology and function, as assessed by both conventional and advanced echocardiographic parameters. In addition, the study assessed the effects of FCM administration on iron stores, exercise capacity [six-minute walk test (6MWT) and cardiopulmonary exercise testing (peak VO₂, maximal and mean VE/VCO₂ slope)], quality of life (KCCQ and EQ-5D-5L questionnaires), and prognostic biomarkers (NT-proBNP). This was a prospective observational study including 86 patients with HFrEF and iron deficiency from the HF outpatient clinic of the Third Department of Cardiology AUTH, General Hospital of Thessaloniki “Hippokration.” The follow-up period was 12 months and included regular clinical assessment, laboratory testing (including iron indices and NT-proBNP), 6MWT, cardiopulmonary exercise testing, and echocardiography. At baseline, all patients received intravenous FCM. The mean age of the study population was 71.8±10.7 years, and 83% were male. During follow-up, patients received a mean total dose of 1.35±0.58 g FCM, and 58% no longer met criteria for iron deficiency at study completion. During follow-up, 9 cardiac (11%) and 7 non-cardiac deaths (8%) were recorded. Functional capacity improved significantly, as demonstrated by the 6MWT (431±113 vs. 469±134 m, p<0.001) and peak VO₂ (11.3±3.2 vs. 12.1±4.1 mL/kg/min, p<0.001). Median NT-proBNP decreased from 723 (2354) to 309 (1596) ng/mL (p<0.001). Regarding echocardiographic parameters, LVEF increased from 29.3±7.8% at baseline to 32.5±10.6% at 12 months (p<0.001), and LV global longitudinal strain (GLS) improved from −7.89% (3.8) to −8.62% (4.7) (p=0.001), while LVEDVi decreased (89.9 [39.5] vs. 87.8 [52.3] mL/m², p=0.027). Diastolic dysfunction improved in 27% of patients (p=0.017). With respect to LA functional parameters, LAVi (37.4 [25.1] vs. 32 [19.7] mL/m², p<0.001), LAFi, and LA reservoir strain increased significantly. Most RV functional indices also showed significant improvement, with TAPSE (1.64±0.36 vs. 1.76±0.35 cm, p=0.008) and TDI S′ (p<0.001) increasing significantly, and RV free-wall strain improving from 16.9±4.5% to 19.4±5.4% (p<0.001). In multivariable analysis, changes in LVEF (p<0.001), RV free-wall strain (p<0.001), and LV GLS (p=0.01) were the only parameters independently associated with the increase in peak VO₂, collectively explaining 42% of the improvement. Subgroup analyses revealed no significant differences across various clinical characteristics. In conclusion, intravenous FCM administration in patients with HFrEF and iron deficiency was associated with adequate total body iron restoration, improvement in symptoms and functional capacity, and partial reversal of cardiac dysfunction, representing a key mechanistic pathway underlying the improvement in exercise capacity.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tsarouchas, Anastasios-Stylianos
- Τσαρουχάς, Αναστάσιος-Στυλιανός
Subjects
dc:subject × 14- Καρδιακή ανεπάρκεια
- Σιδηροπενία
- Εργοσπιρομετρία
- Υπερηχοκαρδιογραφία
- Heart failure
- Iron deficiency
- Cardiopulmonary exercise test
- Echocardiography
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Καρδιολογία και Καρδιοαγγειακά νοσήματα
- Clinical Medicine
- Medical and Health Sciences
- Cardiology and Cardiovascular Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/60980